Advertisement
Advertisement
TNDM
Tandem Diabetes Care, Inc.
21.13
USDSponsored
-1.50
-6.62%
Mar 06, 15:59 UTC -5
Closed
After-Market
21.12
-0.02
-0.08%
TNDM Earnings Reports
Positive Surprise Ratio
TNDM beat 21 of 41 last estimates.
51%
Next Report
Date of Next Report
Apr 28, 2026
Estimate for Q1 26 (Revenue/ EPS)
$245.26M
/-$0.44
Implied change from Q4 25 (Revenue/ EPS)
-15.54%
/+4300.00%
Implied change from Q1 25 (Revenue/ EPS)
+4.62%
/-33.33%
Tandem Diabetes Care, Inc. earnings per share and revenue
On Feb 19, 2026, TNDM reported earnings of -0.01 USD per share (EPS) for Q4 25, beating the estimate of -0.08 USD, resulting in a 88.08% surprise. Revenue reached 290.38 million, compared to an expected 282.57 million, with a 2.77% difference. The market reacted with a +32.67% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 22 analysts forecast an EPS of -0.44 USD, with revenue projected to reach 245.26 million USD, implying an increase of 4300.00% EPS, and decrease of -15.54% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Opko Health Inc.
Report Date
Feb 26, 2026 For Q4 25
Estimate
-$0.06
Actual
-$0.04
Surprise
+42.28%
Integra LifeSciences Holdings
Report Date
Feb 26, 2026 For Q4 25
Estimate
$0.81
Actual
$0.83
Surprise
+1.68%
Neuropace, Inc. Common Stock
Report Date
Mar 03, 2026 For Q4 25
Estimate
-$0.15
Actual
-$0.08
Surprise
+48.22%
OrthoPediatrics Corp. Common Stock
Report Date
Feb 26, 2026 For Q4 25
Estimate
-$0.34
Actual
-$0.43
Surprise
-25.36%
Delcath Systems Inc
Report Date
Feb 26, 2026 For Q4 25
Estimate
-$0.06
Actual
-$0.05
Surprise
+20.51%
Sight Sciences, Inc. Common Stock
Report Date
Mar 04, 2026 For Q4 25
Estimate
-$0.14
Actual
-$0.08
Surprise
+43.66%
908 Devices Inc. Common Stock
Report Date
Mar 03, 2026 For Q4 25
Estimate
-$0.07
Actual
-$0.05
Surprise
+29.97%
Anteris Technologies Global Corp. Common Stock
Report Date
Feb 26, 2026 For Q4 25
Estimate
-$0.59
Actual
-$0.74
Surprise
-24.18%
Treace Medical Concepts, Inc. Common Stock
Report Date
Feb 27, 2026 For Q4 25
Estimate
-$0.15
Actual
-$0.15
Surprise
+1.96%
Masimo Corporation
Report Date
Feb 26, 2026 For Q4 25
Estimate
$1.50
Actual
-Surprise
-
FAQ
What were Tandem Diabetes Care, Inc.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Tandem Diabetes Care, Inc. reported EPS of -$0.01, beating estimates by 88.08%, and revenue of $290.38M, 2.77% above expectations.
How did the market react to Tandem Diabetes Care, Inc.'s Q4 2025 earnings?
The stock price moved up 32.67%, changed from $18.52 before the earnings release to $24.57 the day after.
When is Tandem Diabetes Care, Inc. expected to report next?
The next earning report is scheduled for Apr 28, 2026.
What are the forecasts for Tandem Diabetes Care, Inc.'s next earnings report?
Based on 22
analysts, Tandem Diabetes Care, Inc. is expected to report EPS of -$0.44 and revenue of $245.26M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement